Haaglanden Medisch Centrum Stichting — Clinical Trial Site

59 Registered trials

30 Currently recruiting

Organisation

Haaglanden Medisch Centrum Stichting

Location

Leidschendam, Netherlands

Identifier

ORG-100029478

Address

Lijnbaan 32, 2512 VA, Netherlands

Departments

Afdeling Longoncologie
Cardiology
Clinical Oncology
Department of Neurology/Neuro-Oncology
Department of Surgery
Emergency Department
Gynecology and obstetrics
Hematology
Intensive Care
Internal medicine
Internal Oncology
interne geneeskunde
Interne oncologie
Longgeneeskunde
Lung
Medical Oncology
Medische Oncologie
N/A
Neurology
Neurosurgery
Oncologie
Oncology
Pediatrics
Pulmonary Science
Pulmonology
Radiation Oncology
Reproductive medicine and gynecology
Sports Medicine
Surgery
Trialbureau Haaglanden Medisch Centrum

Clinical trials at this site (59)

Search interface

Shortened 12 months duration of androgen receptor signalling agent in combination with androgen deprivation therapy in patients with low-vol… Recruiting

2023-506698-36-00 low-volume metastatic castration-sensitive prostate can 5 2024-02-02
A feasibility study of SGM-101, a fluorochrome-labeled anti-carcinoembryonic antigen monoclonal antibody for the intraoperative detection of… Recruiting

2024-510767-30-00 Brain metastases 4 2023-12-04
Renal Lifecycle Trial: A Randomized Controlled Clinical Trial to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in … Recruiting

2023-508389-13-00 Combined endpoint of all-cause mortality, kidney failur 5 2022-11-08
Prevention of opioid-induced constipation in patients with advanced cancer. Recruiting

2023-509462-38-00 Patients with advanced cancer. 11 2022-10-25
RAINBO: Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials (MMRd-GREEN) Recruiting

2023-503267-42-00 Patients with a histological diagnosis of mismatch- rep 5 2022-06-10
The efficacy of the addition of TRAstuzumab and Pertuzumab to neoadjuvant chemoradiation: a randomized multi-center study in resectable HER2… Recruiting

2024-513797-22-00 HER2 positive esophageal adenocarcinoma 5 2022-03-09
Multicentre, open-label, randomized, controlled, parallel arms clinical trial of induction chemotherapy followed by chemoradiotherapy versus… Recruiting

2024-512526-28-00 Locally recurrent rectal cancer 5 2020-10-28
SGM-LARRC: Multicenter, open-label, controlled, parallel arms clinical study on the performance of SGM-101, a fluorochrome-labeled anti-carc… Recruiting

2024-510768-21-00 Rectal cancer 4 2019-10-16
Prospective Randomized Open-label Trial to Evaluate risk faCTor management in patients with Unruptured intracranial aneurysms (PROTECT-U) Recruiting

2024-517236-22-00 Intradural saccular unruptured aneurysm 5 2017-09-20
DRUP trial Recruiting

2023-509152-33-00 Advanced solid tumor 4 2016-07-25
POEM Study Ended

2024-519386-21-01 Gestational diabetes mellitus 5 2025-01-29
A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Patients with previously treated KRAS G12C-positive… Ended

2024-510908-37-00 KRAS G12C-Positive Advanced or Metastatic Non-Small Cel 5 2024-08-28
ARTEMIS - A research study to look at how ziltivekimab works compared to placebo in people who have had a heart attack Ended

2023-506876-28-00 The medical condition we are investigating is type 1 AM 5 2024-08-01
DUTCH-WAIST Ended

2022-501392-81-00 Obesity 6 2024-07-25
Phase 3 study of belzutifan plus pembrolizumab as adjuvant treatment in renal cell carcinoma (RCC) Ended

2023-505023-31-00 Renal cell carcinoma 5 2023-11-17
Safe, effective and cost-effective oxygen saturation targets for children and adolescents with respiratory distress: a randomized controlled… Ended

2023-504817-56-00 Bronchiolitis 6 2023-09-05
OCEAN(a)-Outcomes – Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction – Outcomes trial Ended

2022-501608-85-00 Cardiovascular disease (atherosclerotic cardiovascular 5 2023-05-09
Does progesterone luteal phase support increase live birth rates in couples undergoing intra-uterine insemination with Mild Ovarian HyperSti… Ended

2022-501534-33-00 Unexplained Subfertility, infertility 6 2023-03-06
A Placebo-Controlled Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With Atherosclerotic Cardiovascular Disease … Ended

2023-507795-51-00 atherosclerotic heart and blood vessel disease (the nar 5 2022-05-17
A study of Sacituzumab Govitecan Versus Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC). Ended

2024-512148-50-00 Non-small cell lung cancer 5 2022-03-03
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic… Ended

2023-506752-24-00 Locally recurrent inoperable or metastatic HR+/HER2- br 5 2021-08-05
Induction chemotherapy for locally advanced rectal cancer. Ended

2023-509758-74-00 Locally advanced rectal cancer 4 2021-07-21
A Phase 3 study of Tafasitamab plus Lenalidomide in addition to Rituximab, versus Lenalidomide plus Rituximab in patients With Relapsed/Refr… Ended

2023-504684-16-00 follicular lymphoma (FL) and marginal zone lymphoma (MZ 5 2021-06-05
Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteremia (SAFE-trial) Ended

2024-515398-90-01 Staphylococcus aureus bacteremia 5 2020-08-17